Strategikon Pharma
Clinical Study Planning - Clinical Trial Business Operations | Clinical Maestro®
San Francisco, United States · Founded 2017 · $7.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- SaaS
- Website
- strategikon.com
- Total Funding
- $7.0M
- Last Round
- $7.0M Series AFeb 2024
- Rounds
- 2
About
Develops Clinical Maestro, AI-powered software suite that reduces clinical trial costs by 80% or more.
Summary
Strategikon Pharma is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Feb 2024. Investors include Osage Venture Partners, Debiopharm Innovation and Hearstlab.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company